Controlled Drugs and Substances Act

The Controlled Drugs and Substances Act (CDSA) is Canada's primary federal statute governing controlled substances — the law that classifies which drugs are controlled, organises them into numbered schedules, and defines the criminal offences attached to each. It is enacted by the Parliament of Canada and administered principally by Health Canada.

The schedule numbers used by the CDSA follow Canadian legislative logic and carry no equivalence to classification numbers in other countries. A compound in one tier under the CDSA may sit in a completely different tier under another system, or may not be controlled at all.

What it means in practice

Substances enter or leave the CDSA schedules primarily through regulatory amendment rather than a full vote of Parliament, allowing new or emerging substances to be added relatively quickly.

The Act creates criminal offences for possession, trafficking, production, and import and export of controlled substances. The applicable offence category depends on which schedule the substance appears in; specific penalty ranges are jurisdictional values not stated on this page.

Health Canada can grant exemptions from the Act's prohibitions under its administrative authority. These have been used to permit supervised consumption facilities, to authorise clinical research, and to allow access to certain controlled substances for therapeutic purposes on compassionate grounds — without removing those substances from the schedules.

The Act's reach extends beyond named substances to cover specified isomers, salts, and preparations derived from listed compounds. The scope of those provisions is a matter for legal interpretation.

How jurisdictions vary

The CDSA applies in Canada. Many countries have enacted drug-control legislation in response to the same international treaty obligations, but each translates those commitments into its own legislative categories and numbering.

The United States uses the Controlled Substances Act, with a Schedule I through V structure. The United Kingdom uses the Misuse of Drugs Act, organised around a Class A, B, C framework with a separate licensing schedule. A substance's Canadian schedule number does not indicate where it falls under either of those systems, or under any other country's law.

Cannabis presents a notable case: Parliament subsequently enacted separate legislation creating a legal framework for cannabis, while leaving the CDSA in place for conduct outside that framework.

What is contested

Several substances remain in the CDSA schedules while clinical evidence for their therapeutic applications has grown. Health Canada has acknowledged this gap by issuing exemptions permitting accepted medical use under controlled conditions, without formal rescheduling.

The distinction matters: a substance's schedule placement reflects the regulatory record at the time of listing, not a continuous re-evaluation of subsequent research. What the classification asserts in law is not the same as what the current clinical literature records.

Scope and currency

This entry is not legal advice and does not describe the law as it applies to the reader's location or circumstances. The position stated here reflects what was known as of 24 August 2026.

For substance-specific legal status — jurisdiction, source, and date — consult the Legal Status section on each substance's own page.